GNTA · Genenta Science S.p.A. · Financials
Market Cap
$40.54M
Shares
48.22M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-6.53M
+26.7%
FY2025
Diluted EPS
-0.33
+32.7%
FY2025
Operating Cash Flow
-6.87M
-10.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| EUR | 2.7M | 4.81M | 6.47M | 5.34M | 3.39M | 4.69M | 3.7M |
| EUR | 3.9M | 4.95M | 5.26M | 5.71M | 2.3M | 901.77K | 921.52K |
| EUR | 28.08K | 44.52K | 42.45K | 6140 | 4889 | 1900 | — |
| EUR | 6.6M | 9.76M | 11.73M | 11.04M | 5.69M | 5.59M | 4.62M |
| EUR | -6.6M | -9.76M | -11.73M | -11.04M | -5.69M | -5.59M | -4.62M |
| EUR | 73.91K | 851.82K | 87.49K | 2.57M | 157.94K | -1788 | 26.78K |
| EUR | -6.53M | -8.91M | -11.65M | -8.48M | -5.53M | -5.59M | -4.6M |
| EUR | -6.53M | -8.91M | -11.65M | -8.48M | -5.53M | -5.59M | -4.6M |
| EUR | -6.45M | -9.05M | -11.45M | -8.48M | -5.53M | -5.59M | -4.6M |
| shares | 19.71M | 18.27M | 18.22M | 18.22M | 15.08M | — | — |
| shares | 19.71M | 18.27M | 18.22M | 18.22M | 15.08M | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.